Today: 1 July 2026
Browse Category

Mergers and Acquisitions 31 December 2025 - 31 January 2026

Netflix flips to an all-cash $82.7 billion Warner Bros. Discovery bid as Paramount clock ticks

Netflix flips to an all-cash $82.7 billion Warner Bros. Discovery bid as Paramount clock ticks

Netflix has shifted to an all-cash bid for Warner Bros. Discovery’s studio and streaming units, keeping the price steady at $82.7 billion in a move to edge out Paramount Skydance. The updated offer would pay Warner shareholders $27.75 per share, according to a filing on Tuesday. The move comes just a day ahead of Paramount’s tender offer deadline on Jan. 21, following a drop in Netflix shares that made the stock portion less attractive. Netflix announced it plans to back the revised offer using cash reserves, credit lines, and committed financing.
20 January 2026
···
Kenvue stock edges up as Kimberly-Clark vote nears — the deal spread traders are watching

Kenvue stock edges up as Kimberly-Clark vote nears — the deal spread traders are watching

New York, Jan 14, 2026, 11:12 EST — Regular session Kenvue Inc shares ticked up roughly 0.4% to $17.08 on Wednesday, continuing a stretch of modest fluctuations as the stock moves mainly on deal speculation. The gain followed Kimberly-Clark’s submission of extra documents to the U.S. Securities and Exchange Commission related to its intended purchase of the consumer health firm.
14 January 2026
···
Merck stock dips after $32 billion Revolution Medicines talks report, with Gardasil and Keytruda in focus

Merck stock dips after $32 billion Revolution Medicines talks report, with Gardasil and Keytruda in focus

New York, Jan 9, 2026, 20:01 — Market closed. Merck & Co shares slipped on Friday following reports that the pharma giant is in talks to acquire cancer-focused biotech Revolution Medicines for as much as $32 billion. Merck ended the day down 0.4% at $110.53, after swinging between $110.26 and $112.46.
10 January 2026
····
Merck stock slips after Cidara tender offer; $9 billion R&D hit and HPV schedule shift in focus

Merck stock slips after Cidara tender offer; $9 billion R&D hit and HPV schedule shift in focus

New York, Jan 7, 2026, 15:40 — Regular session Merck & Co shares were down about 0.3% at $108.59 in afternoon trade on Wednesday after the drugmaker said it had completed its cash tender offer for Cidara Therapeutics and expected to finish the acquisition through a merger later in the day. The company said the deal will be treated as an asset acquisition, lifting 2026 research and development expense by about $9.0 billion and cutting earnings per share by roughly 30 cents in the first 12 months. “The acquisition of Cidara strengthens and complements our expanding respiratory portfolio,” Chief Executive Robert M. Davis said. Merck.com
7 January 2026
·····
Uber stock slips as SpotHero acquisition-talk report emerges in year-end trade

Uber stock slips as SpotHero acquisition-talk report emerges in year-end trade

NEW YORK, December 31, 2025, 14:53 ET — Regular session Uber Technologies shares were down about 0.3% at $81.87 in afternoon trade on Wednesday, after moving between $81.60 and $82.48, following a report the company has been in talks to acquire parking reservation app SpotHero. The Information said SpotHero has raised more than $110 million and was most recently valued at about $290 million, citing PitchBook data. The Information
31 December 2025
··
1 2 3 4 … 7

Stock Market Today

  • Sensex, Nifty Edge Up as Auto Leads, Rainfall Deficit Caps Gains
    July 1, 2026, 1:22 AM EDT. The BSE Sensex added 181.28 points to 76,659.95 and NSE Nifty50 rose 49.90 points to 23,915.65, lifted by auto stocks but held back by a 40% rainfall deficit in June and a lack of progress in US-Iran talks. Sector action was mixed - Nifty Media up 1.63%, Nifty Metal down 0.72%. Among major Sensex players, Mahindra & Mahindra gained 2.05%, Titan added 1.44%. Bajaj Finserv lost 2.13%. Crude hovered near $73 a barrel, helping inflation views, but market tone turned cautious on geopolitics. Analysts pointed to monsoon deficiencies as an increasing drag on the farm sector and economy.
Go toTop